NCT01956292

Brief Summary

Evaluation of blood pressure variability in the acute phase of intraparenchimal cerebral haemorrhage and its consequences to clinical outcome

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2013

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2013

Completed
2 days until next milestone

Study Start

First participant enrolled

October 1, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 8, 2013

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

October 8, 2013

Status Verified

October 1, 2013

Enrollment Period

1 year

First QC Date

September 29, 2013

Last Update Submit

October 5, 2013

Conditions

Intraparenchimal Cerebral Haemorrhage

Outcome Measures

Primary Outcomes (1)

  • evaluation of blood pressure varibility on clinical course in patients with cerebral haemorrhage

    Day 7

Study Arms (1)

Intraparenchimal cerebral haemorrhage

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients admitted to hospital for intraparenchimal cerebral haemorrhage

You may qualify if:

  • hospitalization only for spontaneous intraparenchimal cerebral haemorrhage
  • age over 18 years

You may not qualify if:

  • cerebral haemorrhage secondary to other causes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AO Sant'Anna Hospital

Como, Como, 22100, Italy

Location

Central Study Contacts

Simone Vidale, MD

CONTACT

00390315859282simone.vidale@hsacomo.org

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

September 29, 2013

First Posted

October 8, 2013

Study Start

October 1, 2013

Primary Completion

October 1, 2014

Study Completion

June 1, 2015

Last Updated

October 8, 2013

Record last verified: 2013-10

Locations

IT(1)